Aurora Cannabis Inc - Asset Resilience Ratio

Latest as of December 2025: 6.72%

Aurora Cannabis Inc (ACB) has an Asset Resilience Ratio of 6.72% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ACB strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$52.09 Million
Cash + Short-term Investments

Total Assets

$775.29 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2025)

This chart shows how Aurora Cannabis Inc's Asset Resilience Ratio has changed over time. See Aurora Cannabis Inc net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Aurora Cannabis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ACB stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $52.09 Million 6.72%
Total Liquid Assets $52.09 Million 6.72%

Asset Resilience Insights

  • Limited Liquidity: Aurora Cannabis Inc maintains only 6.72% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Aurora Cannabis Inc Industry Peers by Asset Resilience Ratio

Compare Aurora Cannabis Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
Drug Manufacturers - Specialty & Generic 0.76%
Eris Lifesciences Limited
NSE:ERIS
Drug Manufacturers - Specialty & Generic 0.58%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.01%
Lotus Pharmaceutical Co Ltd
TW:1795
Drug Manufacturers - Specialty & Generic 0.49%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 11.69%
Changzhou Qianhong Biopharma Co Ltd
SHE:002550
Drug Manufacturers - Specialty & Generic 18.70%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%
Sun Pharma Advanced Research Company Limited
NSE:SPARC
Drug Manufacturers - Specialty & Generic 0.64%

Annual Asset Resilience Ratio for Aurora Cannabis Inc (2009–2025)

The table below shows the annual Asset Resilience Ratio data for Aurora Cannabis Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.06% $550.82K $847.77 Million -0.42pp
2024-03-31 0.48% $4.04 Million $840.14 Million +0.34pp
2022-03-31 0.14% $1.33 Million $926.38 Million +0.01pp
2021-03-31 0.14% $3.75 Million $2.72 Billion -0.10pp
2020-03-31 0.24% $7.04 Million $2.92 Billion -2.31pp
2019-03-31 2.55% $143.80 Million $5.64 Billion -0.59pp
2018-03-31 3.14% $59.59 Million $1.90 Billion -1.49pp
2017-03-31 4.63% $14.98 Million $323.82 Million +4.24pp
2016-03-31 0.39% $71.00K $18.32 Million +0.38pp
2015-03-31 0.01% $1.50K $13.53 Million -97.50pp
2012-03-31 97.51% $1.13 Million $1.16 Million +0.25pp
2011-03-31 97.26% $1.35 Million $1.39 Million +8.79pp
2010-03-31 88.46% $1.53 Million $1.73 Million -8.62pp
2009-03-31 97.09% $1.58 Million $1.62 Million --
pp = percentage points

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$173.24 Million
Market Cap Rank
#17189 Global
#4011 in USA
Share Price
$2.93
Change (1 day)
+0.34%
52-Week Range
$2.92 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more